Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Effects of fish-oil supplementation on myocardial fatty acids in humans

Background: Increased fish or fish-oil consumption is associated with reduced risk of cardiac mortality, especially sudden death. This benefit putatively arises from the incorporation of the long-chain n–3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) into cardiomyocyte phospholipids.

Objective: The study examined the kinetics of incorporation of n–3 fatty acids into human myocardial membrane phospholipids during supplementation with fish oil and {alpha}-linolenic acid–rich flaxseed oil.

Design: Patients with low self-reported fish intake (<1 fish meal/wk and no oil supplements) accepted for elective cardiac surgery involving cardiopulmonary bypass were randomly allocated to 1 of 6 groups: no supplement; fish oil (6 g EPA+DHA/d) for either 7, 14, or 21 d before surgery; flaxseed oil; or olive oil (both 10 mL/d for 21 d before surgery). Right atrial appendage tissue removed during surgery and blood collected at enrollment and before surgery were analyzed for phospholipid fatty acids.

Results: Surgery rescheduling resulted in a range of treatment times from 7 to 118 d. In the fish-oil-treated subjects, accumulation of EPA and DHA in the right atrium was curvilinear with time and reached a maximum at {approx}30 d of treatment and displaced mainly arachidonic acid. Flaxseed oil supplementation yielded a small increase in atrial EPA but not DHA, whereas olive oil did not significantly change atrial n–3 fatty acids.

Conclusion: The results of the present study show that dietary n–3 fatty acids are rapidly incorporated into human myocardial phospholipids at the expense of arachidonic acid during high-dose fish-oil supplementation.

Published on 08-04-2008
Authors: Robert G Metcalf, Michael J James, Robert A Gibson, James RM Edwards, John Stubberfield, Robert Stuklis, Kurt Roberts-Thomson, Glenn D Young and Leslie G Cleland
Source: From the Rheumatology Unit (RGM, MJJ, and LGC),, the Cardiothoracic Surgery Unit (JRME, JS, and RS),, and the Cardiovascular Research Centre (GDY and KR-T),, Royal Adelaide Hospital, Adelaide, Australia;School of Agriculture Food and Wine (RAG), and the School of Medicine (MJJ, LGC, and GDY),, University of Adelaide, Adelaide, Australia; and the Hanson Institute, Adelaide, Australia (MJJ and LGC),